Cardiff Oncology, Inc. Common Stock
CRDF
CRDF: Cardiff Oncology Inc is a clinical-stage, biotechnology company, developing treatment options for cancer patients in indications with the greatest medical need, including KRAS-mutated metastatic colorectal cancer, pancreatic cancer, metastatic castrate-resistant prostate cancer and leukemias.
moreShow CRDF Financials
Recent trades of CRDF by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CRDF's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on CRDF's company Twitter account
Number of mentions of CRDF in WallStreetBets Daily Discussion
Recent insights relating to CRDF
Recent picks made for CRDF stock on CNBC
ETFs with the largest estimated holdings in CRDF
Flights by private jets registered to CRDF